⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 15, 2014The LancetOpen Access

Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

Ben J. Slotman Harm van Tinteren J. Praag J. Knegjens Sherif Y. El Sharouni M. Hatton Astrid Keijser Corinne Faivre‐Finn Suresh Senan

View Full Paper

Ask AI

Bookmark

Share

Abstract

Dutch Cancer Society (CKTO), Dutch Lung Cancer Research Group, Cancer Research UK, Manchester Academic Health Science Centre Trials Coordination Unit, and the UK National Cancer Research Network.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Slotman et al. (2014) studied this question.

synapsesocial.com/papers/69d93a4fda3af5b1d0836120 https://doi.org/10.1016/s0140-6736(14)61085-0

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results DatabaseCohort Study · 2006 · 1,844 citations
2Small Cell Lung Cancer: Have We Made Any Progress Over the Last 25 Years?Human Clinical Trial · 2007 · 212 citations
3Prophylactic Cranial Irradiation in Extensive Small-Cell Lung CancerOriginal Research · 2007 · 1,135 citations
4Role of Radiation Therapy in the Combined-Modality Treatment of Patients With Extensive Disease Small-Cell Lung Cancer: A Randomized StudyCohort Study · 1999 · 387 citations
5Thoracic radiation therapy improves the overall survival of patients with extensive‐stage small cell lung cancer with distant metastasisPrognostic Study · 2011 · 95 citations

More related papers

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial1975
Calculating the number needed to treat for trials where the outcome is time to an event1999
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer2010

More from The Lancet

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trialSun,
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialSun,